Cargando…
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
Graft-versus-host disease (GVHD) is a major barrier to the widespread use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for treating hematologic malignancies. Myeloid-derived suppressor cells (MDSCs) have been recognized as crucial immunosuppressive cells in various pathologic se...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687551/ https://www.ncbi.nlm.nih.gov/pubmed/30737483 http://dx.doi.org/10.1038/s41375-019-0394-z |
_version_ | 1783442740064813056 |
---|---|
author | Zhang, Jilu Chen, Hui-Ming Ma, Ge Zhou, Zuping Raulet, David Rivera, Andreana L. Chen, Shu-Hsia Pan, Ping-Ying |
author_facet | Zhang, Jilu Chen, Hui-Ming Ma, Ge Zhou, Zuping Raulet, David Rivera, Andreana L. Chen, Shu-Hsia Pan, Ping-Ying |
author_sort | Zhang, Jilu |
collection | PubMed |
description | Graft-versus-host disease (GVHD) is a major barrier to the widespread use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for treating hematologic malignancies. Myeloid-derived suppressor cells (MDSCs) have been recognized as crucial immunosuppressive cells in various pathologic settings. Here, we investigated whether the unique functional properties of MDSCs could be harnessed to control allo-HSCT-associated GVHD. Using multiple murine GVHD/GVL models including both MHC-mismatched and miHA-mismatched, we demonstrated that treatment with CD115+ MDSCs efficiently suppressed GVHD but did not significantly impair graft-versus-leukemia (GVL) activity, leading to 80% and 67% protection in treated mice in GVHD and GVL models, respectively. The mechanism for this dissociation of GVHD from GVL, specifically the emergence of donor-derived NKG2D(+) CD8 T cells with a memory phenotype in MDSC-treated recipient mice, was identified. NKG2D expression on donor T cells was required for eradication of allogeneic lymphoma cells. Furthermore, long-term surviving MDSC recipients that exhibited cytolytic activities against allogeneic leukemia cells had a significantly increased percentage of T regulatory cells and, more importantly, NKG2D(+) CD8 T cells. These findings indicate that MDSCs can be used as a novel cell-based therapy to suppress GVHD while maintaining GVL activities through selective induction of NKG2D(+) CD8 memory T cells. |
format | Online Article Text |
id | pubmed-6687551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-66875512019-08-09 The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. Zhang, Jilu Chen, Hui-Ming Ma, Ge Zhou, Zuping Raulet, David Rivera, Andreana L. Chen, Shu-Hsia Pan, Ping-Ying Leukemia Article Graft-versus-host disease (GVHD) is a major barrier to the widespread use of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for treating hematologic malignancies. Myeloid-derived suppressor cells (MDSCs) have been recognized as crucial immunosuppressive cells in various pathologic settings. Here, we investigated whether the unique functional properties of MDSCs could be harnessed to control allo-HSCT-associated GVHD. Using multiple murine GVHD/GVL models including both MHC-mismatched and miHA-mismatched, we demonstrated that treatment with CD115+ MDSCs efficiently suppressed GVHD but did not significantly impair graft-versus-leukemia (GVL) activity, leading to 80% and 67% protection in treated mice in GVHD and GVL models, respectively. The mechanism for this dissociation of GVHD from GVL, specifically the emergence of donor-derived NKG2D(+) CD8 T cells with a memory phenotype in MDSC-treated recipient mice, was identified. NKG2D expression on donor T cells was required for eradication of allogeneic lymphoma cells. Furthermore, long-term surviving MDSC recipients that exhibited cytolytic activities against allogeneic leukemia cells had a significantly increased percentage of T regulatory cells and, more importantly, NKG2D(+) CD8 T cells. These findings indicate that MDSCs can be used as a novel cell-based therapy to suppress GVHD while maintaining GVL activities through selective induction of NKG2D(+) CD8 memory T cells. 2019-02-08 2019-08 /pmc/articles/PMC6687551/ /pubmed/30737483 http://dx.doi.org/10.1038/s41375-019-0394-z Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Zhang, Jilu Chen, Hui-Ming Ma, Ge Zhou, Zuping Raulet, David Rivera, Andreana L. Chen, Shu-Hsia Pan, Ping-Ying The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. |
title | The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. |
title_full | The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. |
title_fullStr | The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. |
title_full_unstemmed | The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. |
title_short | The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. |
title_sort | mechanistic study behind suppression of gvhd while retaining gvl activities by myeloid-derived suppressor cells. |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687551/ https://www.ncbi.nlm.nih.gov/pubmed/30737483 http://dx.doi.org/10.1038/s41375-019-0394-z |
work_keys_str_mv | AT zhangjilu themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT chenhuiming themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT mage themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT zhouzuping themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT rauletdavid themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT riveraandreanal themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT chenshuhsia themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT panpingying themechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT zhangjilu mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT chenhuiming mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT mage mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT zhouzuping mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT rauletdavid mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT riveraandreanal mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT chenshuhsia mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells AT panpingying mechanisticstudybehindsuppressionofgvhdwhileretaininggvlactivitiesbymyeloidderivedsuppressorcells |